|
|
||||||||
ORIGINAL RESEARCH COMMUNICATION |
1 From the Departments of Nutrition (JS), Epidemiology (JS and J), and Biostatistics (J and JC), School of Public Health, University of North Carolina, Chapel Hill, and the Division of Hypertension, University of Mississippi Medical Center, Jackson (DWJ).
2 Supported by a grant from the American Heart Association.
3 Address reprint requests to J Stevens, Departments of Nutrition and Epidemiology, CB 7400, University of North Carolina, Chapel Hill, NC 27514. E-mail: june_stevens{at}unc.edu.
| ABSTRACT |
|---|
|
|
|---|
Objective: The effects of using 4 different outcomes and 3 different measures of effect as criteria for comparing BMI cutoffs were shown with the use of data from 45- to 64-y-old African American and white women.
Design: Data were from the Cancer Prevention Study I (CPS-I) and the Atherosclerosis Risk in Communities (ARIC) Study. The outcomes were mortality (9211 deaths), diabetes (757 cases), hypertension (1518 cases), and hypertriglyceridemia (1264 cases). The measures of effect were incidence rate, rate ratio, and rate difference. The BMI in African American women that was associated with a risk equivalent to that of white women with a BMI of 30 was estimated.
Results: There was no significant association between BMI and mortality in African American women. The BMI in African American women that was associated with a risk of diabetes equivalent to that of white women with a BMI of 30 was 28.034.5, depending on the measure of effect. For hypertension, the equivalent risk in African American women occurred at a BMI of <1838, depending on the measure of effect. There was no BMI at which African American women had an incidence rate or rate ratio for hypertriglyceridemia that was as high as that of white women with a BMI of 30.
Conclusion: BMI cutoffs associated with equivalent risk across ethnic groups differ widely depending on the outcome and the risk estimate.
Key Words: Epidemiology African American women mortality diabetes hypertension hypertriglyceridemia body weight body mass index obesity Cancer Prevention Study I Atherosclerosis Risk in Communities Study
| INTRODUCTION |
|---|
|
|
|---|
Although no such statements were made in regard to other ethnic groups, many studies have shown that the risk of obesity in other ethnic groups, including African Americans (5), Mexican Americans (6), and Native Americans (7, 8), may differ from that in whites. The issue of whether different cutoffs should be used for different ethnic groups is a complex one. The World Health Organization report, the National Institutes of Health Evidence Report, and the more recent report that was focused on Asia all relied heavily on published results on the associations between BMI and mortality and morbidity. The reports show results with several outcomes and various types of risk estimates. Yet, nowhere in these reports were the criteria for determining the BMI cutoffs for overweight or obesity explicitly listed, and a decision rule for determining whether different BMI cutoffs are needed in different ethnic groups was not stated.
The purpose of this study was to compare the results obtained when different decision rules were used to evaluate BMI cutoffs across ethnic groups. By way of illustration, we show analyses of data from African American and white women. We calculated the BMI value in African American women that was associated with a risk equivalent to that of white women with a BMI of 30, the currently accepted cutoff for obesity (3). Four different outcomes and 3 different measures of effect were compared.
| SUBJECTS AND METHODS |
|---|
|
|
|---|
30 y (9). American Cancer Society volunteers recruited participants, who completed a questionnaire concerning their personal health and medical history. The subjects' ethnicity was determined by self-identification with the use of a checklist, and no attempts were made to assess admixture. The subjects' self-reported height (without shoes) and weight (in indoor clothing) were collected, and their vital status was determined annually from October 1960 through 1965 and thereafter in 1971 and 1972 and was confirmed by death certificates. The study was approved by the relevant institutional review boards.
We restricted this analysis to African American and white women who were between 45 and 64 y of age (n = 352171). Participants who responded by proxy (n = 13239), were missing data for pertinent variables (n = 33643), or were pregnant at baseline (n = 69) were excluded. To avoid confounding by smoking, we excluded both current and former smokers (n = 106496). To avoid confounding by preexisting illness, we excluded those who had involuntarily lost
4.5 kg (10 lb) body weight over the previous 2 y, those who died within the first year of follow-up, and those who reported heart disease, stroke, or cancer other than skin cancer (n = 61107). The final sample included 193135 white women and 3160 African American women.
Atherosclerosis Risk in Communities Study
The associations between BMI and incident diabetes, hypertension, and hypertriglyceridemia were examined by using data from the Atherosclerosis Risk in Communities (ARIC) Study, a prospective, multicenter investigation of atherosclerosis and cardiovascular disease (10). Between 1987 and 1989, 15792 men and women aged 4564 y were examined in 4 US communities. The cohort was reexamined in 3 additional clinic visits, with an average of 3 y between visits. The study protocol was approved by the institutional review committee for human protection at each of the 5 participating universities.
For these analyses, participants who were neither white nor African American were excluded and only women were studied (n = 8685). Ethnicity was determined by self-identification with the use of a checklist, and no attempts were made to assess admixture. Twenty-six African American women in the Minneapolis and Washington County field centers were excluded because their number was too small to permit modeling associations within the African American women in those centers. We also excluded cohort members who were not reexamined after the baseline visit (n = 570) and participants who were missing data for pertinent variables (n = 51) or who had values out of the quality-control range (n = 19).
Participants were classified as having diabetes if they had a glucose value
6.99 mmol/L (126 mg/dL) after fasting for
8 h, had one nonfasting glucose value
11.1 mmol/L (200 mg/dL), reported that a physician had told them they had diabetes, or reported taking medication for diabetes. Participants were classified as having hypertension if their systolic blood pressure was
140 mm Hg, their diastolic blood pressure was
90 mm Hg, or they reported having taken an antihypertensive drug in the past 2 wk. Finally, participants were classified as having hypertriglyceridemia if they had a fasting triacylglycerol concentration >2.26 mmol/L (200 mg/dL).
Participants were instructed to fast for
12 h before the clinic appointment and to bring all prescription and nonprescription drugs used in the 2 wk preceding the examination. Details of the laboratory methods (11, 12) and repeatability estimates (13, 14) are available elsewhere.
Height was measured to the nearest centimeter with the use of a metal rule attached to a wall and a standard triangular headboard. Weight was measured in pounds with the use of a beam balance while the subject wore a scrub suit and no shoes.
Statistical methods
Associations between BMI and incidence rates of mortality and morbidity were examined with the use of Poisson regressions (15). These analyses were performed with the use of the SAS procedure PROC GENMOD (16). We used the quadratic form of BMI with BMI centered to the ethnic-specific mean. On the basis of these models, we estimated the expected incidence rates for a range of BMI values. Incidence rates are expressed as the number of events (death, diabetes, hypertension, or hypertriglyceridemia) per 1000 person-years (the sum of the number of event-free years observed for each subject divided by 1000). Using expected incidence rates estimated from the Poisson regressions, we calculated rate ratios and rate differences by using a BMI of 21.0 as the reference. The risk associated with a BMI of 30 in white women was estimated, and the BMI value associated with the same level of risk in African American women was calculated. Here the term risk is used as a general term that includes the 3 measures of effect studied here, ie, incidence rate, rate ratio, and rate difference.
The baseline characteristics included in the models as covariates for analyses of mortality in the CPS-I were age, education, physical activity, and alcohol consumption. The confounding effects of smoking and preexisting illness on the association between BMI and mortality were handled by exclusions. For analyses of the associations between BMI and morbidity in the ARIC data set, we used smoking status (current, former, and never) and study center as covariates in addition to the covariates used in the CPS-I analysis. Because it was not our intention to adjust for social or economic factors that contribute to ethnic differences (17), separate models were run for each ethnic group.
| RESULTS |
|---|
|
|
|---|
|
|
|
A BMI of 21 was also used as the reference in the evaluation of mortality rate differences, and therefore the rate difference was zero in both the African American and white women at that BMI. With increasing BMI, the rate difference increased in the white women and tended to increase in the African American women. For the white women with a BMI of 30, the rate difference was 3/1000 person-years. An equivalent difference was calculated for the African American women with a BMI of 35.5.
Overall there were 319 cases of diabetes in the African American women and 438 cases in the white women. In contrast with the results for mortality, BMI and diabetes were significantly associated in both the African American and the white women. As shown in Figure 2
, the incidence rates increased similarly in both groups with increasing BMI. The differences in the incidence rates were consistent across a wide range of BMI values. Nevertheless, the rate ratios were considerably lower in the African American women than in the white women at high BMI values. This divergence was driven by the higher rate of diabetes in the reference BMI group in the African American women (10/1000 person-years) than in the white women (5/1000 person-years).
|
|
|
|
| DISCUSSION |
|---|
|
|
|---|
The influence of these other factors on the risks experienced by African American and white women argues against the use of incidence rates as a criterion for setting BMI cutoffs. For all the outcomes examined here, there were important differences in the incidence rates of the 2 ethnic groups at the BMI reference value. The choice of 21.0 as the BMI reference value in the present study was arbitrary, and any BMI within the normal range (18.525.0) would have been equally applicable to this example.
Although assigning BMI cutoffs to produce equivalence in the overall burden of disease has some appeal, if the goal is to identify a BMI value at which risk is higher because of an elevation in BMI, then some type of measure that considers differences in baseline risk is needed. Both rate ratios and rate differences incorporate the level of risk at BMI reference values. However, we find the rate ratio the less attractive of the 2 measures of effect because equivalent multiplicative increases in risk can be associated with very different increases in the number of cases. The increase in the number of cases above that in persons with reference weight seems to be the most meaningful estimate for public health and policy decisions.
Among the outcomes that could be used to set a BMI cutoff for obesity, mortality has several appealing qualities. Mortality is unique, extreme, and easily and precisely assessed. However, in the present study [as in some other studies (5)], no significant association between BMI and mortality was detected in the African American women. This implies that no BMI is better than another in terms of promoting longevity. This finding is so counterintuitive that it is difficult to accept. An association may not have been found in the present study because of unidentified sources of confounding or limitations in statistical power.
It would be difficult to defend the use of any one disease or risk factor over that of any other to set standards for obesity. A measure such as disability-adjusted life years offers a logical option that could be used as an outcome to set obesity standards (18). This measure is the sum of the years of life lost and the years lived with a disability, adjusted for the severity of the disability. Of course, numerous subjective decisions must be made to determine what constitutes a disability and to establish scores for the severity of different disabilities.
Some of the differences in BMI-associated risk noted in the present study between the African American and white women could have been because of differences in body composition. Wagner and Heyward (19) recently reviewed biological differences in blacks and whites. They noted that blacks have greater bone mineral density and body protein content than do whites, resulting in a greater fat-free body density. They also pointed out differences in the distribution of subcutaneous and visceral fat and in the length of the limbs relative to the trunk. Deurenberg et al (20) showed that for the same body fat, age, and sex, African Americans have a BMI that is 1.3 units lower than that of whites. If excess body fat is the critical variable that conveys obesity-associated risk, then this would imply that the BMI standard in African Americans should be 1.3 units lower than that of whites. The present study clearly shows that the discrepancies in different disease risks associated with BMI cannot be entirely accounted for by this adjustment.
One strength of the present study is that all outcomes were examined prospectively rather than in cross-section. Therefore, the antecedent-consequence uncertainty was satisfied, and BMI was examined as a predictor of future risk. Another strength is the relatively large number of African American women studied and the availability of data on fasting glucose, lipids, and blood pressure.
A limitation of the CPS-I data was that the baseline BMI measurements for the mortality analyses were collected
40 y ago. Nevertheless, a more recent report from the CPS-II, in which the baseline data were collected in 1982 (21), showed patterns between BMI and all-cause mortality that were similar to those seen in the CPS-I. In both studies, there was no significant effect of BMI on mortality in African American women, whereas there were significant effects of similar magnitude in white women. A limitation common to both the CPS-I and the CPS-II cohorts is that height and weight data were from self-reports. Although self-reported height and weight are in general highly correlated with measured height and weight, with correlation coefficients above 0.9, heavier persons tend to underreport their weight more than leaner persons do (2224). This bias could affect the results of an analysis of BMI and mortality.
Explicitly stating the measures of effect and the outcomes used to determine a BMI cutoff for obesity would aid the quantitative evaluation of cutoffs for different ethnic groups. However, other issues must also be considered in decisions related to policy. In both the CPS-I and ARIC cohorts, ethnicity was determined by self-identification with the use of a checklist. This variable names the cultural, social, and familial group with which the participants identify themselves and should not be overinterpreted. In a multiethnic society such as that in the United States, it is likely that many persons would have difficulty classifying themselves as belonging to only one ethnic group. This ambiguity, together with our lack of insight into what specific components or aspects of ethnicity lead to observed differences in risks, make the justification of different BMI cutoffs more difficult. Because of the enormous stigma attached to obesity and the sensitivity of ethnic issues, it seems unlikely that formal policies setting different cutoffs for different ethnic groups in the United States are feasible.
The adoption of different cutoffs for all persons within different countries seems more feasible. BMI cutoffs can affect policy because they are used to evaluate the health of populations and the need for health promotion activities. Risks for many disease outcomes, however expressed, are generally higher at higher BMI values, and most health professionals view excess adiposity negatively. Therefore, even in groups such as Samoans, in which the scientific evidence may indicate that a higher cutoff could be justified, a policy to set a higher BMI cutoff for obesity may not gain strong support. For advocates of health promotion, evidence indicating the need for a lower BMI cutoff for obesity is of more concern. Thus, a BMI cutoff for obesity that is lower than that accepted in Western countries may become accepted in some Asian countries. Whether the criteria used are quantitative, qualitative, political, or pragmatic, careful examination of the decision rules used to set the definition of obesity in diverse populations is merited.
| ACKNOWLEDGMENTS |
|---|
| REFERENCES |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
J. Stevens, K. P. Truesdale, E. G. Katz, and J. Cai Impact of Body Mass Index on Incident Hypertension and Diabetes in Chinese Asians, American Whites, and American Blacks: The People's Republic of China Study and the Atherosclerosis Risk in Communities Study Am. J. Epidemiol., June 1, 2008; 167(11): 1365 - 1374. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Razak, S. S. Anand, H. Shannon, V. Vuksan, B. Davis, R. Jacobs, K. K. Teo, M. McQueen, S. Yusuf, and for the SHARE Investigators Defining Obesity Cut Points in a Multiethnic Population Circulation, April 24, 2007; 115(16): 2111 - 2118. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. R. Wilson and D. D. McAlpine The effectiveness of screening for obesity in primary care: weighing the evidence. Med Care Res Rev, October 1, 2006; 63(5): 570 - 598. [Abstract] [PDF] |
||||
![]() |
W.-H. Pan, K. M Flegal, H.-Y. Chang, W.-T. Yeh, C.-J. Yeh, and W.-C. Lee Body mass index and obesity-related metabolic disorders in Taiwanese and US whites and blacks: implications for definitions of overweight and obesity for Asians Am. J. Clinical Nutrition, January 1, 2004; 79(1): 31 - 39. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Manson and S. S. Bassuk Obesity in the United States: A Fresh Look at Its High Toll JAMA, January 8, 2003; 289(2): 229 - 230. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |